These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30097505)

  • 1. Evaluation of
    Kuwabara H; Comley RA; Borroni E; Honer M; Kitmiller K; Roberts J; Gapasin L; Mathur A; Klein G; Wong DF
    J Nucl Med; 2018 Dec; 59(12):1877-1884. PubMed ID: 30097505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
    Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
    J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetic Modeling of the Tau PET Tracer
    Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D
    J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
    Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
    J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
    [No Abstract]   [Full Text] [Related]  

  • 9. [
    Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [
    Guehl NJ; Wooten DW; Yokell DL; Moon SH; Dhaynaut M; Katz S; Moody KA; Gharagouzloo C; Kas A; Johnson KA; El Fakhri G; Normandin MD
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2099-2111. PubMed ID: 31332496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Comparison of Tau Radioligands
    Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
    J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau PET imaging with
    Mueller A; Bullich S; Barret O; Madonia J; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):911-919. PubMed ID: 31712323
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of [
    Schmidt ME; Janssens L; Moechars D; Rombouts FJR; Timmers M; Barret O; Constantinescu CC; Madonia J; Russell DS; Sandiego CM; Kolb H
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3176-3185. PubMed ID: 32535652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [
    de Vries BM; Timmers T; Wolters EE; Ossenkoppele R; Verfaillie SCJ; Schuit RC; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BNM; Boellaard R; Golla SSV
    Mol Imaging Biol; 2021 Aug; 23(4):550-559. PubMed ID: 33443720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
    Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L
    J Nucl Med; 2012 Mar; 53(3):415-24. PubMed ID: 22323782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional associations between [
    Teng E; Ward M; Manser PT; Sanabria-Bohorquez S; Ray RD; Wildsmith KR; Baker S; Kerchner GA; Weimer RM
    Neurobiol Aging; 2019 Sep; 81():138-145. PubMed ID: 31280117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.